These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effect of the anticoagulation regimen on endothelial-related coagulation in cardiac surgery patients. Boldt J; Schindler E; Welters I; Wittstock M; Stertmann WA; Hempelmann G Anaesthesia; 1995 Nov; 50(11):954-60. PubMed ID: 8678251 [TBL] [Abstract][Full Text] [Related]
5. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage. Mössinger H; Dietrich W Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S45-50; discussion S50-1, S74-6. PubMed ID: 9647138 [TBL] [Abstract][Full Text] [Related]
6. Effects of Duraflo II heparin-coated cardiopulmonary bypass circuits on the coagulation system, endothelial damage, and cytokine release in patients with cardiac operation employing aprotinin and steroids. Inui K; Shimazaki Y; Watanabe T; Takahashi T; Minowa T; Takeda H; Yanagawa N; Sotoda Y Artif Organs; 1999 Dec; 23(12):1107-12. PubMed ID: 10619929 [TBL] [Abstract][Full Text] [Related]
7. Aprotinin inhibits thrombin formation and monocyte tissue factor in simulated cardiopulmonary bypass. Khan MM; Gikakis N; Miyamoto S; Rao AK; Cooper SL; Edmunds LH; Colman RW Ann Thorac Surg; 1999 Aug; 68(2):473-8. PubMed ID: 10475415 [TBL] [Abstract][Full Text] [Related]
8. The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generation. Tanaka KA; Szlam F; Levy JH Br J Haematol; 2006 Jul; 134(1):77-82. PubMed ID: 16803571 [TBL] [Abstract][Full Text] [Related]
9. A pump-prime aprotinin dose in cardiac surgery: appraisal of its effects on the hemostatic system. Rossi M; Storti S; Martinelli L; Varano C; Marra R; Zamparelli R; Possati G; Schiavello R J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):835-9. PubMed ID: 9412880 [TBL] [Abstract][Full Text] [Related]
10. Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease. Welters I; Menges T; Ballesteros M; Knothe C; Ruwoldt R; Görlach G; Hempelmann G Thromb Res; 1998 Oct; 92(1):1-9. PubMed ID: 9783668 [TBL] [Abstract][Full Text] [Related]
12. Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation. Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Kawashima Y Circulation; 1996 Nov; 94(9 Suppl):II177-81. PubMed ID: 8901742 [TBL] [Abstract][Full Text] [Related]
13. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Miller BE; Tosone SR; Tam VK; Kanter KR; Guzzetta NA; Bailey JM; Levy JH Ann Thorac Surg; 1998 Aug; 66(2):535-40; discussion 541. PubMed ID: 9725399 [TBL] [Abstract][Full Text] [Related]
18. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid. Menichetti A; Tritapepe L; Ruvolo G; Speziale G; Cogliati A; Di Giovanni C; Pacilli M; Criniti A J Cardiovasc Surg (Torino); 1996 Aug; 37(4):401-7. PubMed ID: 8698787 [TBL] [Abstract][Full Text] [Related]
19. Aprotinin and hemostasis monitoring concerns during cardiac surgery. Swartz MF; Fink GW; Searles B J Extra Corpor Technol; 2004 Dec; 36(4):375-83. PubMed ID: 15679283 [TBL] [Abstract][Full Text] [Related]
20. Effects of novel synthetic serine protease inhibitors on postoperative blood loss, coagulation parameters, and vascular relaxation after cardiac surgery. Szabó G; Veres G; Radovits T; Haider H; Krieger N; Bährle S; Miesel-Gröschel C; Niklisch S; Karck M; van de Locht A J Thorac Cardiovasc Surg; 2010 Jan; 139(1):181-8; discussion 188. PubMed ID: 20106364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]